MEDIA

Fluid Biomed Milestones

LATEST NEWS RELEASE

Fluid Biotech Announces Rebranding, Changes Name to Fluid Biomed

JAN 20 2022 | CALGARY, AB

Company unveils new name to convey its focus on medical device innovation
Fluid Biotech, a life sciences company based in Calgary, Alberta, Canada that is pioneering stent technology, is rebranding itself to Fluid Biomed, to emphasize its focus on medical device innovation as it accelerates towards clinical trials. “Fueled by our previous over-subscribed seed financing round, we’ve made tremendous progress as a young firm in the pre-clinical testing of our flagship product: the world’s first bio-absorbable flow-diverting stent to cure the deadly disease of brain aneurysms,” states company co-founder and CEO, Dr. John Wong. “The new company name aligns with our mission of developing the next generation of stents to improve patient well-being and will help us harmonize with strategic medical device manufacturers and financial partners as we enter the next exciting phase of growth”. All other facets of the company remain unchanged and the transition is anticipated to be complete by end of Q1 2022.
NEWS RELEASE

Fluid Biotech Inc. Raises $4.7M USD in Oversubscribed Seed Funding Round

AUG 11 2021, 06:00 ET | PR NEWSWIRE

MEDIA

Fluid Biotech Secures $5.8 Million CAD to Accelerate Development of Innovative Brain Aneurysm Stent

AUG 11 2021 | BETAKIT

MEDIA

ORIGINAL RESEARCH: A novel self-expanding primarily bioabsorbable braided flow-diverting stent for aneurysms: initial safety results

Nov 27 2019 | JNIS

NEWS RELEASE

Fluid Biotech Inc. Publishes Research and Featured in Neuro News, Reaches Deign Freeze Milestone, and Adds Dr. Vitor Pereira to Advisory Board.

MAY 8 2020 | CALGARY, AB

MEDIA

EDITORIAL: Endovascular Stents – Do They Need To Be Permanent?

Mar 19 2020 | SCIENCE DIRECT

MEDIA

Self-expanding bioabsorbable flow-diverting stent shows a favourable safety profile

JAN 14 2020 | NEURO NEWS

MEDIA

UCalgary researchers aim to revolutionize treatment for brain aneurysms

Mar 3 2021 | UNIVERSITY OF CALGARY

“There’s no reason why we can’t leverage what we have learned and created to combat other serious diseases.” — Dr. John Wong
MEDIA

Fluid Biotech wins W21C Innovation Academy

OCT 31 2019 | INNOVATION ACADEMY

MEDIA

Fluid Biotech Wins TENET i2C Competition

JUN 12 2019 | UNIVERSITY OF CALGARY

NEWS RELEASE

Fluid Biotech Closes Pre-Seed Raise and add Dr. William Hunter to Advisory Board

FEB 7 2020 | CALGARY, AB